Nanoparticle-Based Drug Delivery
Nanoparticle-Based Drug Delivery is a research topic within Biomaterials. Science Explorer counts 48k research works in it since 1951. 25.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the development and application of nanoparticle-based drug delivery systems, particularly for cancer therapy. It covers topics such as nanocarriers, surface engineering of nanoparticles, magnetic nanoparticles, tumor targeting, polymeric nanoparticles, and the enhanced permeability and retention (EPR) effect. The research explores the synthesis, functionalization, and biomedical applications of various types of nanoparticles for drug delivery.
- Nanocarriers
- Drug Delivery
- Nanoparticles
- Cancer Therapy
- Surface Engineering
- Magnetic Nanoparticles
- Biomedical Applications
- Tumor Targeting
- Polymeric Nanoparticles
- EPR Effect
- Research works
- 48k fractional, since 1951
- In the world top 10%
- 12k per year above
- Top-10% rate
- 25.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +22% the tick is no change
Which countries lead Nanoparticle-Based Drug Delivery research?
By volume, China and India publish the most (3.5k and 2k works in 2022–2025).
By volume, 2022–2025
- 1 China 3.5k works
- 2 India 2k works
- 3 United States 1k works
- 4 Iran 671 works
- 5 South Korea 281 works
- 6 Italy 255 works
- 7 Russia 250 works
- 8 Türkiye 239 works
- 9 Japan 229 works
- 10 Germany 217 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Nanoparticle-Based Drug Delivery research?
By volume in 2022–2025, Sichuan University publishes the most Nanoparticle-Based Drug Delivery research, followed by Shenyang Pharmaceutical University and Chinese Academy of Sciences.
By volume, 2022–2025
- 1 Sichuan University China 67 works
- 2 Shenyang Pharmaceutical University China 55 works
- 3 Chinese Academy of Sciences China 49 works
- 4 Zhejiang University China 44 works
- 5 Shanghai Jiao Tong University China 43 works
- 6 King Saud University Saudi Arabia 42 works
- 7 Mashhad University of Medical Sciences Iran 40 works
- 8 China Pharmaceutical University China 39 works
- 9 Sun Yat-sen University China 39 works
- 10 Narsee Monjee Institute of Management Studies India 39 works
Who are the leading researchers in Nanoparticle-Based Drug Delivery?
The most-cited researchers publishing on Nanoparticle-Based Drug Delivery include Hongjie Dai, Amirhossein Sahebkar and Wei Huang.
- 1 Hongjie Dai 5.8k citations
- 2 Amirhossein Sahebkar 5.6k citations
- 3 Wei Huang 5.5k citations
- 4 Krzysztof Matyjaszewski 4.4k citations
- 5 Eduarda Fernandes 4.4k citations
- 6 Róbert Langer 4.2k citations
- 7 Younan Xia 3.7k citations
- 8 Zhuang Liu 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Nanoparticle-Based Drug Delivery research done?
The largest centres of Nanoparticle-Based Drug Delivery research in 2022–2025 are Beijing (China), Shanghai (China), Tehran (Iran) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Tabriz.
Largest cities, 2022–2025
Where it is the local speciality
- TabrizIR · 77.1 works9.6×
Location quotient: how much more of its research is in Nanoparticle-Based Drug Delivery than the world average.
Where is the best place to study Nanoparticle-Based Drug Delivery?
Among universities, judged by research, Mashhad University of Medical Sciences, Tabriz University of Medical Sciences and Narsee Monjee Institute of Management Studies score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Mashhad University of Medical Sciences Iran | 70.1 | 22.5% | 14.8× | 40 | +566.0% |
| 2 | Tabriz University of Medical Sciences Iran | 69.8 | 26.8% | 14.6× | 38 | +155.1% |
| 3 | Narsee Monjee Institute of Management Studies India | 68.2 | 21.8% | 27.5× | 39 | +385.2% |
| 4 | Shenyang Pharmaceutical University China | 65.5 | 27.8% | 36.8× | 55 | +44.2% |
| 5 | University of Tabriz Iran | 65.3 | 36.0% | 7.1× | 20 | +246.1% |
| 6 | Jamia Hamdard India | 65.0 | 39.9% | 19.2× | 20 | +32.8% |
| 7 | American University of Sharjah United Arab Emirates | 64.7 | 50.9% | 9.1× | 10 | — |
| 8 | University of Macau Macau | 61.5 | 46.0% | 3.2× | 12 | +457.0% |
| 9 | China Pharmaceutical University China | 61.4 | 26.9% | 16.1× | 39 | +31.4% |
| 10 | Yeungnam University South Korea | 59.2 | 37.6% | 5.5× | 14 | +174.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Nanoparticle-Based Drug Delivery research growing?
Output in 2018–2022 was 22% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Nanoparticle-Based Drug Delivery.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.